We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, a... read more Featured Products: More products

Download Mobile App




Performance of Field Evaluated Malaria Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 22 Sep 2016
The introduction of malaria rapid diagnostic tests (RDTs) has enhanced quick examination of blood samples from suspected malaria patients; however, it is not clear which RDT is the most appropriate in different endemic areas with mono and mixed infections of different parasites.

Regardless of the setting, RDTs require minimal operator training, and yield highly reproducible test interpretations. More...
RDT results are normally rapidly available when the physician is actively managing patients as the test can be completed in less than 20 minutes. They do not require any instrumentation, electricity, special laboratories, or water and these kits are generally cost-beneficial.

Scientists at the Kenya Medical Research Institute (Nairobi, Kenya) and their colleagues evaluated commercial RDTs for malaria on 500 study participants. The study participants included 290 (58%) children younger than 12 years and the other 210 ranged in age from 13 to 64 year. The 181 male participants were a minority of participants while the majority of the participants were the 319 females. The 196 adult women who were not pregnant comprised 39% of the female population.

The team assessed the performance of BinaxNow, SD Bioline, CareStart Malaria, and First Response. These RDTs were compared to thin and thick blood film microscopy and real time polymerase chain reaction (PCR). Amplification and real-time measurements was performed in the AB 7500 analytical PCR system from Applied Biosystems.

Of the 500 participants recruited, 33% were malaria positive by microscopy while 51.2 % were positive by PCR. Compared to microscopy, the sensitivity of the RDTs to detect malaria parasites was 90.3% to 94.8 %, the specificity was 73.3% to 79.3%, the positive predictive value was 62.2% to 68.8%, and the negative predictive value was 94.3% to 96.8%. Compared to PCR, the sensitivity of the RDTs to detect malaria parasites was 71.1% to 75.4%, the specificity was 80.3% to 84.4 %. The RDTs had a moderate measure of agreement with both microscopy of more than 80.1 % and PCR of more than 77.6 %.

The authors concluded that rapid diagnostic tests can be applied in a number of settings with a great potential for impact on public health where they can significantly improve the quality of malaria case management in areas where expert microscopy or PCR methods are not available. This study demonstrated that CareStart, SD Bioline, BinaxNow, and First Response RDTs performed reasonably well in this endemic region for the detection of Plasmodium falciparum. The study was published on September 7, 2016, in the Malaria Journal.

Related Links:
Kenya Medical Research Institute


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.